Product Description
Tirzepatide Sublingual is a compounded tirzepatide formulation designed for sublingual administration under medical supervision. Unlike injectable tirzepatide products, this format is intended to dissolve under the tongue, offering an alternative delivery method within a physician-guided program.
Tirzepatide is a dual incretin receptor agonist that interacts with GLP-1 and GIP pathways, which are involved in metabolic signaling, appetite regulation, and glucose response. These mechanisms are commonly targeted in prescription-based metabolic and weight management programs in the USA.
Tirzepatide Sublingual are designed for use as part of a structured prescription USA program, where eligibility is determined by a licensed healthcare provider. The sublingual format allows for non-injectable administration while remaining within a regulated medical framework.
Unlike over-the-counter supplements marketed for weight support, tirzepatide is a prescription medication that requires medical screening, dosage guidance, and ongoing provider oversight. Sublingual compounded formulations are dispensed by licensed pharmacies in accordance with applicable regulations.
Tirzepatide Sublingual can be obtained through Vigormeds following medical evaluation and prescription approval. This product is intended for use only under professional supervision and according to the provided medical guidelines.